Leadership Overview
Jamjoom Pharma has 4 executives leading key functions including strategy, finance, and operations.
Driven by a commitment to health, Jamjoom Pharma manufactures and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products across the Middle East, Africa, and CIS countries, impacting regional healthcare.
Driven by a commitment to health, Jamjoom Pharma manufactures and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products across the Middle East, Africa, and CIS countries, impacting regional healthcare.
Leadership Roles at Jamjoom Pharma
Tarek Hosni - Chief Executive Officer
Tarek Hosni, the Chief Executive Officer at Jamjoom Pharma, directs the overall strategic vision and operational execution for the company's extensive pharmaceutical and consumer health product portfolio. Overseeing market expansion initiatives across the Middle East, Africa, and CIS countries, Tarek Hosni ensures alignment with Jamjoom Pharma's mission to enhance regional healthcare access. This leadership role involves driving innovation in product development and optimizing distribution channels to meet diverse market demands. By fostering key partnerships and guiding departmental strategies, the Chief Executive Officer ensures sustained growth and market leadership. Tarek Hosni's focus remains on delivering high-quality pharmaceutical solutions and strengthening the company's presence in its core operating regions.
Noor Sheriff - Founder & Chief Executive Officer
Noor Sheriff, the Founder & Chief Executive Officer at Jamjoom Pharma, established the company's foundational principles and continues to guide its strategic direction. Spearheading the company's mission to provide essential pharmaceutical products, over-the-counter medicines, and health-related consumer goods, Noor Sheriff ensures a steadfast commitment to quality and accessibility across the Afrasia region. This leadership position involves cultivating the company's culture and driving long-term growth strategies. By overseeing critical business functions and fostering innovation, the Founder & Chief Executive Officer maintains Jamjoom Pharma's competitive edge. Noor Sheriff's vision propels the company's impact on public health throughout the Middle East, Africa, and CIS countries.
Anwer Mohiuddin - Chief Financial Officer
Anwer Mohiuddin, the Chief Financial Officer at Jamjoom Pharma, manages all financial operations and strategic fiscal planning for the company's extensive manufacturing and marketing activities. Overseeing budgeting, forecasting, and financial reporting, Anwer Mohiuddin ensures robust fiscal health across Jamjoom Pharma's operations in the Middle East, Africa, and CIS countries. This critical role involves optimizing financial performance, managing investment strategies, and ensuring compliance with all regulatory financial standards. By providing insightful financial analysis, the Chief Financial Officer supports executive decision-making and drives profitability. Anwer Mohiuddin's expertise is vital for sustaining the company's growth and expanding its market reach through sound financial management.
Ashraf Hussain - Chief Operating Officer
Ashraf Hussain, the Chief Operating Officer at Jamjoom Pharma, directs the company's manufacturing, supply chain, and operational efficiency across its diverse product lines. Overseeing the production of pharmaceutical products, over-the-counter medicines, and consumer health items, Ashraf Hussain ensures seamless execution of Jamjoom Pharma's market strategies in the Middle East, Africa, and CIS regions. This leadership function involves optimizing production processes, managing logistics, and maintaining stringent quality control standards. By driving operational excellence, the Chief Operating Officer enhances the company's ability to meet market demands effectively. Ashraf Hussain's focus on operational integrity supports Jamjoom Pharma's commitment to delivering reliable healthcare solutions.
Explore Leadership Teams in Manufacturing
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
JS
Founded in 1969, Themis Medicar is a pharmaceutical company that specializes in manufacturing pharmaceuticals and medicinal chemicals for cardiology, pain management, anti-infectives, haematinics, and health and nutrition. Themis Medicare is located in India.
Company Leadership PN
TD
MS
HM
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership MÇ
GO
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates. Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates. In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods. Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system. Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 45 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of "building a healthier Indonesia for everyone one person at a time", Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people. DARYA VARIA
Company Leadership CH
Frequently Asked Questions Regarding Jamjoom Pharma Top Executives and Leadership Team
